Skip to main content
OpenTrials

Clinical trial condition

Agitation

Explore clinical trials studying Agitation. Study availability and eligibility vary by location and protocol.

70 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Agitation trial results

Active, not recruiting

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

NCT05397639

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Alzheimer's Type Dementia, +10 more
Locations
  • Advanced Research Center, Inc. Anaheim, California, United States
  • ATP Clinical Research, Inc. Costa Mesa, California, United States
  • Leading Edge Research LA, LLC Encino, California, United States
  • Neuro Pain Medical Center Fresno, California, United States
View all 44 locations
View Trial Details
Completed

Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

NCT05644262

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Alzheimer Disease, +17 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Howard University Washington D.C., District of Columbia, United States
  • Melgar-Caro Medcenter and Community Research (MCMCR) Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

NCT05557409

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, +18 more
Locations
  • Clinical Research Site Peoria, Arizona, United States
  • Clinical Research Site Tempe, Arizona, United States
  • Clinical Research Site Tucson, Arizona, United States
  • Clinical Research Site Canoga Park, California, United States
View all 55 locations
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)

NCT05271552

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +14 more
Locations
  • BioXcel Clinical Research Site Phoenix, Arizona, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
  • BioXcel Clinical Research Site Daytona Beach, Florida, United States
  • BioXcel Clinical Research Site Lady Lake, Florida, United States
View Trial Details
Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

NCT04010305

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +12 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Lemon Grove, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

NCT04268303

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +16 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Culver City, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View all 15 locations
View Trial Details

Related conditions